InvestorsHub Logo
Followers 1741
Posts 142045
Boards Moderated 4
Alias Born 09/11/2005

Re: NASDAQ2020 post# 132744

Saturday, 11/01/2014 9:19:42 AM

Saturday, November 01, 2014 9:19:42 AM

Post# of 399798
What is going on with this?

--Elite has signed a Manufacturing and License Agreement with Epic Pharma who will manufacture 11 of the 12 approved generics ANDAs recently obtained from MIKAH. This will allow Elite to maximize their profit potential for their generic business while devoting their resources to the development of their abuse resistant products. Isradipine CBE-30 filed by Elite and will be manufactured by Elite and only has 1 competitor in a 6 million dollar market. EPIC will file CBE-30 for the second MIKAH ANDA Dantrolene in June 2014, it has one competitor in a 12 million dollar market
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News